Summary of Sight and Life Special Report: Second Edition
May 2023
Read the 2-page summary of Sight and Life’s MMS Special Report: Second Edition.
UNIMMAP MMS Resources
Explore the latest resources on UNIMMAP MMS research, policy guidance, manufacturing/supply, and advocacy.
Sight and Life MMS Special Report: Second Edition
May 2023
Sight and Life MMS Special Report: Second Edition. Highlights country case studies of MMS adoption, which incorporate formative research findings to identify effective strategies to improve MMS service delivery and secure MMS product supplies.
World Health Organization (WHO) Essential Medicines List
February 2023
The World Health Organization 2023 List of Essential Medicines, which catalogues the medicines WHO considers a minimum requirement for a basic healthcare system, includes MMS.
Sight and Life Special Report: Focusing on Multiple Micronutrient Supplements
April 2020
This report compiles and curates the latest evidence, experience from the field, and resources for the scale up of MMS, and serves as a resource for decision-makers and implementers.
Benefits of Supplementation with Multiple Micronutrients in Pregnancy
August 2019
Commentary introducing the Special issue of the Annals of the New York Academy of Sciences on MMS.
Modifiers of the Effect of Multiple Micronutrient Supplementation on Stillbirth, Birth Outcomes, and Infant Mortality: A Meta-Analysis of Individual Patient Data from 17 Randomised Trials in Low-Income and Middle-Income Countries
August 2019
Article on individual-level modifiers of the effect of MMS on stillbirth, birth outcomes, and infant mortality in low- and middle-income countries.
Review of the Evidence Regarding the Use of Antenatal Multiple Micronutrient Supplements in Low- and Middle-Income Countries
August 2019
Research review on inadequate micronutrient intake in low- and middle-income countries (LMICs); data comparisons between MMS and IFA trials; and cost-effectiveness of MMS.
The Upper Level: Examining the Risk of Excess Micronutrient Intake in Pregnancy from Antenatal Supplements
August 2019
Review of the available information on the risks in pregnancy when the upper intake level (UL) of MMS is exceeded and the potential risk of exceeding the UL if a pregnant woman takes MMS.